SOLV vs BAX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SOLV · Solventum$84.50 ▼ 1.52%
BAX · Baxter International Inc$25.39 ▲ 0.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SOLV +1.3%
- BAX +39.9%
Head to head
| Metric | SOLV | BAX |
|---|---|---|
| Price | $84.50 | $25.39 |
| Change today | ▼ 1.52% | ▲ 0.00% |
| Market cap | $14.34B | $13.14B |
| Return, 3 months | -7.4% | -4.1% |
| Return, year to date | +6.6% | +33.0% |
| Return, 1 year | +1.9% | +38.9% |
| P/E (TTM) | 94.9 | – |
| P/B | 3.0 | 2.0 |
| P/E percentile vs own 5y | 99th | 21st |
| Dividend yield | – | 0.16% |
| Revenue growth (YoY, latest qtr) | -7.0% | +5.0% |
| Net profit growth (YoY) | -100.9% | +739.1% |
| Gross margin | 54.8% | 30.1% |
| Operating margin | 5.2% | 2.3% |
| Net margin | 1.9% | -6.2% |
| Return on equity | 3.2% | -10.5% |
| Analyst target vs. price | +20.9% | -1.5% |
| Analyst buy share | 63% | 0% |
| RSI (14) | 42 | 50 |
| 30-day volatility | 33.2% | 43.9% |
| Max drawdown, 1 year | -27.5% | -29.0% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SOLV is the largest of the group by market value.
- BAX has returned the most over the past year.
- BAX is growing revenue fastest.
- SOLV keeps the most profit per dollar of sales.
- SOLV has been the calmest stock over the last 30 days.